Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Neoplasms | 9 | 2017 | 716 | 2.260 |
Why?
|
| Spinal Fusion | 9 | 2023 | 1286 | 2.050 |
Why?
|
| Lumbar Vertebrae | 14 | 2023 | 1879 | 1.760 |
Why?
|
| Spinal Cord Compression | 7 | 2016 | 235 | 1.690 |
Why?
|
| Thoracic Vertebrae | 5 | 2018 | 597 | 1.440 |
Why?
|
| Spondylolisthesis | 2 | 2023 | 175 | 1.300 |
Why?
|
| Scoliosis | 3 | 2023 | 741 | 1.020 |
Why?
|
| Diskectomy | 5 | 2021 | 209 | 0.950 |
Why?
|
| Neurosurgical Procedures | 7 | 2022 | 2072 | 0.820 |
Why?
|
| Decompression, Surgical | 3 | 2018 | 607 | 0.770 |
Why?
|
| Duodenal Obstruction | 1 | 2020 | 23 | 0.720 |
Why?
|
| Fournier Gangrene | 1 | 2020 | 22 | 0.710 |
Why?
|
| Kidney Calices | 1 | 2019 | 26 | 0.690 |
Why?
|
| Foreign-Body Migration | 2 | 2011 | 219 | 0.670 |
Why?
|
| Spinal Cord Diseases | 2 | 2023 | 292 | 0.670 |
Why?
|
| Urinary Calculi | 1 | 2019 | 90 | 0.660 |
Why?
|
| Rupture, Spontaneous | 1 | 2019 | 362 | 0.640 |
Why?
|
| Gallbladder | 1 | 2020 | 308 | 0.630 |
Why?
|
| Ureteral Obstruction | 1 | 2019 | 293 | 0.590 |
Why?
|
| Electric Conductivity | 1 | 2018 | 405 | 0.580 |
Why?
|
| Ureter | 1 | 2019 | 368 | 0.560 |
Why?
|
| Meningeal Neoplasms | 5 | 2015 | 1248 | 0.540 |
Why?
|
| Radionuclide Imaging | 1 | 2020 | 1972 | 0.530 |
Why?
|
| Kyphosis | 1 | 2018 | 237 | 0.520 |
Why?
|
| Cervical Vertebrae | 3 | 2012 | 980 | 0.520 |
Why?
|
| Equipment and Supplies | 1 | 2018 | 273 | 0.520 |
Why?
|
| Spine | 4 | 2022 | 1118 | 0.490 |
Why?
|
| Hydrocephalus | 2 | 2011 | 764 | 0.490 |
Why?
|
| Injections, Intraventricular | 2 | 2015 | 225 | 0.480 |
Why?
|
| Spondylosis | 2 | 2012 | 84 | 0.470 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2011 | 188 | 0.440 |
Why?
|
| Cobalt | 1 | 2013 | 154 | 0.430 |
Why?
|
| Postoperative Complications | 11 | 2021 | 15633 | 0.420 |
Why?
|
| Chromium | 1 | 2013 | 132 | 0.420 |
Why?
|
| Catheters, Indwelling | 2 | 2015 | 426 | 0.410 |
Why?
|
| Orthopedic Procedures | 3 | 2018 | 1265 | 0.390 |
Why?
|
| Bone Plates | 2 | 2012 | 466 | 0.390 |
Why?
|
| Esophageal Perforation | 1 | 2011 | 65 | 0.380 |
Why?
|
| Microsurgery | 3 | 2023 | 795 | 0.380 |
Why?
|
| Paraparesis | 1 | 2010 | 15 | 0.370 |
Why?
|
| Carcinoma | 2 | 2020 | 2330 | 0.350 |
Why?
|
| Hernia | 1 | 2010 | 68 | 0.350 |
Why?
|
| Spinal Fractures | 2 | 2013 | 705 | 0.340 |
Why?
|
| Surgical Instruments | 1 | 2012 | 383 | 0.340 |
Why?
|
| Cerebral Ventricles | 1 | 2011 | 542 | 0.330 |
Why?
|
| Pituitary Neoplasms | 6 | 2022 | 1324 | 0.320 |
Why?
|
| Kidney Diseases | 1 | 2019 | 2091 | 0.320 |
Why?
|
| Dura Mater | 1 | 2010 | 290 | 0.310 |
Why?
|
| Acromegaly | 2 | 2022 | 310 | 0.310 |
Why?
|
| Palliative Care | 4 | 2017 | 3598 | 0.310 |
Why?
|
| Karnofsky Performance Status | 2 | 2018 | 166 | 0.300 |
Why?
|
| Osteomyelitis | 1 | 2011 | 407 | 0.290 |
Why?
|
| Low Back Pain | 1 | 2015 | 984 | 0.270 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 1271 | 0.270 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1924 | 0.250 |
Why?
|
| Resins, Synthetic | 2 | 2021 | 25 | 0.240 |
Why?
|
| Back Pain | 3 | 2018 | 545 | 0.230 |
Why?
|
| Pain Measurement | 5 | 2020 | 3551 | 0.220 |
Why?
|
| Spinal Cord | 2 | 2015 | 1819 | 0.220 |
Why?
|
| Pulmonary Artery | 1 | 2011 | 1927 | 0.210 |
Why?
|
| Retrospective Studies | 20 | 2023 | 80646 | 0.210 |
Why?
|
| Meningioma | 1 | 2011 | 1218 | 0.210 |
Why?
|
| Middle Aged | 34 | 2021 | 220917 | 0.210 |
Why?
|
| Humans | 59 | 2023 | 761578 | 0.210 |
Why?
|
| Pain | 4 | 2023 | 5073 | 0.200 |
Why?
|
| Lumbosacral Region | 1 | 2023 | 293 | 0.200 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2023 | 140 | 0.200 |
Why?
|
| Sciatica | 2 | 2019 | 97 | 0.190 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2021 | 59 | 0.190 |
Why?
|
| Radiosurgery | 2 | 2021 | 1342 | 0.190 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2021 | 37 | 0.190 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 5146 | 0.170 |
Why?
|
| Lipomatosis, Multiple Symmetrical | 1 | 2019 | 8 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3313 | 0.170 |
Why?
|
| Calculi | 1 | 2019 | 48 | 0.170 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 87 | 0.170 |
Why?
|
| Spinal Diseases | 1 | 2004 | 564 | 0.170 |
Why?
|
| Adult | 27 | 2023 | 221200 | 0.160 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 1740 | 0.160 |
Why?
|
| Psoas Muscles | 1 | 2019 | 66 | 0.160 |
Why?
|
| Registries | 1 | 2015 | 8224 | 0.160 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2021 | 179 | 0.160 |
Why?
|
| Schistosoma haematobium | 1 | 2018 | 13 | 0.160 |
Why?
|
| Treatment Outcome | 10 | 2023 | 64684 | 0.150 |
Why?
|
| Schistosomiasis haematobia | 1 | 2018 | 15 | 0.150 |
Why?
|
| Male | 31 | 2023 | 360841 | 0.150 |
Why?
|
| Radiography | 3 | 2015 | 6965 | 0.150 |
Why?
|
| Debridement | 1 | 2020 | 493 | 0.140 |
Why?
|
| Sigmoid Diseases | 1 | 2017 | 59 | 0.140 |
Why?
|
| Egypt | 1 | 2017 | 97 | 0.140 |
Why?
|
| Reoperation | 6 | 2021 | 4303 | 0.140 |
Why?
|
| Human Growth Hormone | 1 | 2022 | 642 | 0.140 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 173 | 0.140 |
Why?
|
| Lung Neoplasms | 5 | 2016 | 13382 | 0.140 |
Why?
|
| Aged | 21 | 2020 | 169308 | 0.140 |
Why?
|
| Life Expectancy | 2 | 2013 | 1242 | 0.130 |
Why?
|
| Glioma | 2 | 2009 | 3455 | 0.130 |
Why?
|
| Middle East | 1 | 2017 | 231 | 0.130 |
Why?
|
| Female | 31 | 2021 | 392688 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2019 | 20569 | 0.130 |
Why?
|
| Lost to Follow-Up | 1 | 2016 | 123 | 0.120 |
Why?
|
| Pelvis | 1 | 2019 | 733 | 0.120 |
Why?
|
| Diverticulitis | 1 | 2017 | 185 | 0.120 |
Why?
|
| Nerve Block | 1 | 2021 | 706 | 0.110 |
Why?
|
| Radiology Information Systems | 1 | 2018 | 529 | 0.110 |
Why?
|
| Survival Analysis | 2 | 2017 | 10090 | 0.110 |
Why?
|
| Causality | 1 | 2020 | 1242 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 1166 | 0.110 |
Why?
|
| Polyradiculopathy | 1 | 2013 | 23 | 0.110 |
Why?
|
| Joint Prosthesis | 1 | 2015 | 253 | 0.110 |
Why?
|
| Morphine | 1 | 2017 | 657 | 0.110 |
Why?
|
| Urinary Bladder | 1 | 2019 | 1152 | 0.110 |
Why?
|
| Foreign Bodies | 1 | 2017 | 402 | 0.110 |
Why?
|
| Bibliometrics | 1 | 2017 | 352 | 0.110 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 9031 | 0.110 |
Why?
|
| Radiculopathy | 1 | 2015 | 202 | 0.110 |
Why?
|
| Sarcoidosis | 1 | 2018 | 521 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2021 | 1496 | 0.100 |
Why?
|
| Morbidity | 1 | 2018 | 1751 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2019 | 36426 | 0.100 |
Why?
|
| Young Adult | 9 | 2020 | 59254 | 0.090 |
Why?
|
| Thyroid Nodule | 1 | 2018 | 764 | 0.090 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2012 | 195 | 0.090 |
Why?
|
| Pinealoma | 1 | 2011 | 52 | 0.090 |
Why?
|
| Adenoma | 3 | 2020 | 2163 | 0.090 |
Why?
|
| Hematoma, Subdural | 1 | 2011 | 127 | 0.090 |
Why?
|
| Fracture Fixation | 1 | 2013 | 366 | 0.090 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2011 | 118 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 12973 | 0.090 |
Why?
|
| Patient Care Team | 2 | 2013 | 2521 | 0.090 |
Why?
|
| Pituitary Gland | 1 | 2013 | 635 | 0.090 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 39107 | 0.090 |
Why?
|
| Sarcoma, Synovial | 1 | 2011 | 153 | 0.090 |
Why?
|
| Aftercare | 1 | 2015 | 914 | 0.080 |
Why?
|
| Titanium | 1 | 2012 | 485 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 58983 | 0.080 |
Why?
|
| Quality of Life | 4 | 2021 | 13367 | 0.080 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 273 | 0.080 |
Why?
|
| Candidiasis | 1 | 2011 | 365 | 0.080 |
Why?
|
| Proteoglycans | 1 | 2012 | 803 | 0.080 |
Why?
|
| Recurrence | 3 | 2017 | 8466 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2012 | 683 | 0.080 |
Why?
|
| Stereotaxic Techniques | 1 | 2011 | 555 | 0.080 |
Why?
|
| Cadaver | 1 | 2012 | 1358 | 0.070 |
Why?
|
| Stents | 1 | 2019 | 3179 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 13642 | 0.070 |
Why?
|
| Dacarbazine | 1 | 2010 | 559 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2022 | 54423 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2015 | 646 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2011 | 617 | 0.070 |
Why?
|
| Device Removal | 1 | 2011 | 630 | 0.070 |
Why?
|
| Brain Edema | 1 | 2010 | 604 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3688 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2012 | 1836 | 0.060 |
Why?
|
| Video-Assisted Surgery | 1 | 2004 | 51 | 0.060 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 952 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2018 | 22176 | 0.060 |
Why?
|
| Craniotomy | 1 | 2009 | 741 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2012 | 1391 | 0.060 |
Why?
|
| Odontoid Process | 1 | 2004 | 46 | 0.060 |
Why?
|
| Supratentorial Neoplasms | 1 | 2005 | 159 | 0.060 |
Why?
|
| France | 2 | 2018 | 497 | 0.050 |
Why?
|
| Endoscopy | 1 | 2013 | 1851 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2018 | 3482 | 0.050 |
Why?
|
| Hemangioblastoma | 1 | 2003 | 62 | 0.050 |
Why?
|
| Adolescent | 5 | 2018 | 88323 | 0.050 |
Why?
|
| Laminectomy | 1 | 2023 | 225 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2004 | 226 | 0.050 |
Why?
|
| Delayed-Action Preparations | 2 | 2022 | 962 | 0.050 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2003 | 151 | 0.050 |
Why?
|
| Microspheres | 1 | 2005 | 784 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 3808 | 0.050 |
Why?
|
| Periodontal Dressings | 1 | 2020 | 5 | 0.050 |
Why?
|
| Prognosis | 3 | 2017 | 29629 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2009 | 8528 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 6180 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15843 | 0.040 |
Why?
|
| Somatostatin | 1 | 2022 | 447 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 2022 | 392 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2005 | 1642 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 2400 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3617 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4431 | 0.040 |
Why?
|
| Cell Movement | 1 | 2011 | 5205 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2011 | 9281 | 0.040 |
Why?
|
| Congo | 1 | 2018 | 13 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2010 | 3424 | 0.040 |
Why?
|
| Praziquantel | 1 | 2018 | 34 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 8601 | 0.040 |
Why?
|
| Anthelmintics | 1 | 2018 | 83 | 0.040 |
Why?
|
| Time Factors | 3 | 2021 | 39970 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11120 | 0.040 |
Why?
|
| Amyloidosis | 1 | 2004 | 817 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 2895 | 0.030 |
Why?
|
| Brain | 3 | 2019 | 27121 | 0.030 |
Why?
|
| Patient Selection | 1 | 2009 | 4244 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2021 | 1814 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 2015 | 21019 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 1702 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 9001 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 1935 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2021 | 997 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7406 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3420 | 0.030 |
Why?
|
| Cytarabine | 1 | 2015 | 698 | 0.030 |
Why?
|
| Observer Variation | 1 | 2018 | 2606 | 0.030 |
Why?
|
| Travel | 1 | 2018 | 796 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2018 | 1170 | 0.020 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2010 | 83 | 0.020 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2010 | 63 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 2010 | 0.020 |
Why?
|
| Prolactinoma | 1 | 2010 | 114 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 11122 | 0.020 |
Why?
|
| Intestines | 1 | 2018 | 1910 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 2651 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2021 | 41493 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2013 | 6815 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8633 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20099 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1835 | 0.020 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2010 | 617 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2018 | 3905 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 14665 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 1422 | 0.020 |
Why?
|
| Contrast Media | 1 | 2018 | 5307 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4576 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 2005 | 216 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10212 | 0.010 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2005 | 350 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3597 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8656 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 2645 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7391 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 74212 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4740 | 0.010 |
Why?
|
| Biopsy | 1 | 2011 | 6766 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10554 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 2529 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11076 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12725 | 0.010 |
Why?
|
| Melanoma | 1 | 2015 | 5709 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 14607 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2010 | 4399 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18398 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2002 | 1468 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 4317 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2002 | 1499 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13510 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 42231 | 0.000 |
Why?
|
| Animals | 1 | 2018 | 168475 | 0.000 |
Why?
|
| Child | 1 | 2011 | 80157 | 0.000 |
Why?
|
Concepts
(251)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_